Invesco
CVAC

Invesco’s CureVac CVAC Stock Holding History

Invesco’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,263
Closed -$66.6K – 3801
2025
Q2 		$66.6K Sell
12,263
-113
-0.9% -$448 ﹤0.01% 3700
2025
Q1 		$34.3K Buy
12,376
+836
+7% +$2.91K ﹤0.01% 3723
2024
Q4 		$39.4K Buy
11,540
+14
+0.1% +$40 ﹤0.01% 3712
2024
Q3 		$33.9K Sell
11,526
-1,397
-11% -$4.6K ﹤0.01% 3722
2024
Q2 		$43.9K Buy
12,923
+1,628
+14% +$5.33K ﹤0.01% 3832
2024
Q1 		$34.2K Buy
+11,295
New +$39.6K ﹤0.01% 3823
2023
Q1 		– Sell
-23,776
Closed -$143K – 3894
2022
Q4 		$143K Sell
23,776
-318
-1% -$2.35K ﹤0.01% 3768
2022
Q3 		$189K Sell
24,094
-1,187
-5% -$13.8K ﹤0.01% 3698
2022
Q2 		$344K Sell
25,281
-64,294
-72% -$1.06M ﹤0.01% 3515
2022
Q1 		$1.76M Buy
89,575
+49,050
+121% +$979K ﹤0.01% 2833
2021
Q4 		$1.39M Buy
40,525
+12,434
+44% +$500K ﹤0.01% 2933
2021
Q3 		$1.53M Buy
28,091
+2,676
+11% +$161K ﹤0.01% 2931
2021
Q2 		$1.87M Buy
+25,415
New +$2.54M ﹤0.01% 2882

Other funds holding CVAC

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco's CVAC Position: Q3 2025 in Review

Invesco sold out of CureVac (CVAC) in Q3 2025, closing a stake of 12,263 shares — an estimated $66.6K sold.

Invesco first reported a position in CVAC in Q2 2021 and held it in 13 quarters. The position peaked at $1.87M in Q2 2021. 94 funds tracked by Wall St. Rank hold CVAC as of Q3 2025.

  • Invesco reported no remaining CureVac position as of Q3 2025 after selling out during the quarter.
  • Invesco sold 12,263 CureVac shares in Q3 2025, an estimated $66.6K.
  • Invesco first reported a position in CureVac in Q2 2021 and held it in 13 quarters.
  • Invesco's CureVac position peaked at $1.87M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held CureVac as of Q3 2025.

Based on Invesco's 13F filing for Q3 2025, filed 13 Nov 2025.